Completes $5.9 Million of Financing

Bone Biologics Completes $5.9 Million of Financing

July 23, 2018 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics (OTCQB: BBLG), a developer of orthobiologic products for domestic and international spine fusion markets,…